Schamberg's Disease

oPatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

Synonyms: progressive pigmented purpuric dermatitis, Gougerot-Blum capillaritis, itching purpura, pigmented purpuric eruption

Schamberg's disease was first described by Schamberg in 1901 in a 15 year-old boy. It represents benign dermatoses with purpura due to leaking from capillaries close to the skin surface. It most often affects the legs and spreads slowly. The discoloration is brown/orange due to haemosiderin deposition in the skin.

Pigmented purpuric reactions have five disease types:[1][2]

  • Progressive pigmentary purpura or Schamberg's disease.
  • Pigmented purpuric lichenoid dermatitis of Gougerot and Blum - red/brown papules and plaques in men - which responds to psoralen combined with ultraviolet A (PUVA) treatment.
  • Purpura annularis telangiectodes - rare, with a preponderance in young females and manifests as annular erythematous plaques and patches.
  • Eczematoid-like purpura of Doucas and Kapetanakis - occurs in men, with bilateral intensely itchy lesions on legs.
  • Lichen aureus - a localised persistent form of pigmented purpuric dermatitis.[3]

There is clinical and histological overlap between these and they may actually represent variable presentations of the same disease process.

The condition is rare. One study, in a UK hospital-based dermatology practice serving a population of 300,000, identified only ten cases of purpuric pigmented dermatosis (of which Schamberg's disease is only one type) during a 10-month period.[4] It is more common in males and can occur at any age. It has been stated as the most common cause of petechiae in children[1] - however, it is thought that this may not actually be the case.[5] There has been a case report of four family members with Schamberg's disease suggesting a possible genetic link.[6]

Save time & improve your PDP on Patient.co.uk

  • Notes Add notes to any clinical page and create a reflective diary
  • Track Automatically track and log every page you have viewed
  • Print Print and export a summary to use in your appraisal
Click to find out more »

The underlying cause is not known. However, the following have been postulated:

  • Recent viral infection.
  • Hypersensitivity to an unknown causal agent.
  • Aberrant cell-mediated immunity (perivascular infiltrate has specific types of CD cells only).
  • Associated with certain medications - thiamine, aspirin, chlordiazepoxide and paracetamol.[7] It has also been reported with bezafibrate.[7]

There are no symptoms apart from itching and patients note their skin looks blotchy. For some this is enough to cause psychological distress. However, some patients have reported pains in their limbs - which may be coincidental.

Lesions are most commonly on the lower limbs bilaterally but can occur anywhere or be unilateral. A case involving the genitals has been reported.

The lesions consist of:

  • Asymmetrical brown/orange patches.
  • Non-blanchable purpura.
  • Petechiae called "cayenne pepper" spots (develop at the edge of old lesions).

Patterns can vary, eg annular, linear. There may also be associated lichenification, scaling and pruritic marks.

Other causes of purpura:

  • Blood tests - including platelets and clotting - are usually normal.
  • Autoantibody screen and hepatitis serology should be performed.
  • Skin biopsy - histology reveals a capillaritis of dermal vessels. Other changes that may be seen include perivascular inflammatory infiltrate, endothelial hypertrophy with extravasation of blood cells and haemosiderin-laden macrophages.[1]
  • Examination of the skin using a dermatoscope may be helpful.[4]

Any suspected precipitants should be withdrawn.

  • Itching - treat with mild topical corticosteroid or antihistamines.
  • One study has reported good results with narrow band ultraviolet light.[10]
  • Another study reported the successful use of aminaphtone, a drug normally used in other venous conditions such as chronic venous congestion of the lower limbs.[11]
  • Superimposed infection - will need antibiotics.
  • Systemic steroids - no real evidence of their benefit.[1]

Other tried treatments include vitamin C supplements, laser therapy and wearing support hosiery to prevent venous stasis.[2] There is no evidence of definite benefit of the former two. Immunosuppressants have also been used.[2] Psoralen therapy has been used and the results look promising.[2][12]

Schamberg's disease usually runs a chronic course with frequent exacerbations and remissions.The rash may be present for many years with slow extension. Lesions may occasionally disappear spontaneously.

There are three reports of patients with Schamberg's disease developing T-cell lymphoma.[1]

Further reading & references

  1. Tristani-Firouzi P, Meadows KP, Vanderhooft S; Pigmented purpuric eruptions of childhood: a series of cases and review of literature.; Pediatr Dermatol. 2001 Jul-Aug;18(4):299-304.
  2. Sardana K, Sarkar R, Sehgal VN; Pigmented purpuric dermatoses: an overview.; Int J Dermatol. 2004 Jul;43(7):482-8.
  3. Kim MJ, Kim BY, Park KC, et al; A case of childhood lichen aureus. Ann Dermatol. 2009 Nov;21(4):393-5. Epub 2009 Nov 30.
  4. Mehregan D et al; Pigmented Purpuric Dermatitis, Medscape, Jan 2010
  5. Torrelo A, Requena C, Mediero IG, et al; Schamberg's purpura in children: a review of 13 cases.; J Am Acad Dermatol. 2003 Jan;48(1):31-3.
  6. Sethuraman G, Sugandhan S, Bansal A, et al; Familial pigmented purpuric dermatoses. J Dermatol. 2006 Sep;33(9):639-41.
  7. Nishioka K, Katayama I, Masuzawa M, et al; Drug-induced chronic pigmented purpura.; J Dermatol. 1989 Jun;16(3):220-2.
  8. Ugajin T, Satoh T, Yokozeki H, et al; Mycosis fungoides presenting as pigmented purpuric eruption. Eur J Dermatol. 2005 Nov-Dec;15(6):489-91.
  9. Nikam BP, Singh NJ, Shetty DD; Primary benign hypergammaglobulinemic purpura of Waldenstrom masquerading as Indian J Dermatol Venereol Leprol. 2011 Mar-Apr;77(2):205-8.
  10. Fathy H, Abdelgaber S; Treatment of pigmented purpuric dermatoses with narrow-band UVB: a report of six J Eur Acad Dermatol Venereol. 2011 May;25(5):603-6. doi: 10.1111/j.1468-3083.2010.03806.x.
  11. de Godoy JM, Batigalia F; Aminaphtone in the control of Schamberg's disease. Thromb J. 2009 Jun 11;7:8.
  12. Seckin D, Yazici Z, Senol A, et al; A case of Schamberg's disease responding dramatically to PUVA treatment. Photodermatol Photoimmunol Photomed. 2008 Apr;24(2):95-6.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Gurvinder Rull
Current Version:
Peer Reviewer:
Dr Hannah Gronow
Last Checked:
19/08/2011
Document ID:
1723 (v22)
© EMIS